IN2014KN01490A - - Google Patents
Info
- Publication number
- IN2014KN01490A IN2014KN01490A IN1490KON2014A IN2014KN01490A IN 2014KN01490 A IN2014KN01490 A IN 2014KN01490A IN 1490KON2014 A IN1490KON2014 A IN 1490KON2014A IN 2014KN01490 A IN2014KN01490 A IN 2014KN01490A
- Authority
- IN
- India
- Prior art keywords
- tablet
- relates
- solid dosage
- present
- oral solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Abstract
The present invention relates to an oral solid dosage form in particular a tablet comprising sorafenib tosylate polymorphic form III.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261589518P | 2012-01-23 | 2012-01-23 | |
EP12152165 | 2012-01-23 | ||
PCT/EP2013/051219 WO2013110644A1 (en) | 2012-01-23 | 2013-01-23 | Pharmaceutical composition containing crystalline sorafenib tosylate |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014KN01490A true IN2014KN01490A (en) | 2015-10-23 |
Family
ID=48872897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1490KON2014 IN2014KN01490A (en) | 2012-01-23 | 2013-01-23 |
Country Status (7)
Country | Link |
---|---|
US (1) | US9227938B2 (en) |
EP (1) | EP2806860B1 (en) |
CY (1) | CY1126099T1 (en) |
ES (1) | ES2949817T3 (en) |
IN (1) | IN2014KN01490A (en) |
PL (1) | PL2806860T3 (en) |
WO (1) | WO2013110644A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656656A (en) * | 2013-12-18 | 2014-03-26 | 北京科源创欣科技有限公司 | Sorafenib tosylate pharmaceutical composition and preparation method |
RU2747525C2 (en) * | 2019-11-06 | 2021-05-06 | Общество с ограниченной ответственностью "АМЕДАРТ" | Pharmaceutical preparation in tablet form and method for its preparation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000042012A1 (en) | 1999-01-13 | 2000-07-20 | Bayer Corporation | φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS |
SG155996A1 (en) | 2004-09-29 | 2009-10-29 | Bayer Schering Pharma Ag | Thermodynamically stable form of bay 43-9006 tosylate |
SG160364A1 (en) | 2005-03-07 | 2010-04-29 | Bayer Schering Pharma Ag | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer |
WO2008008733A2 (en) * | 2006-07-10 | 2008-01-17 | Elan Pharma International Ltd. | Nanoparticulate sorafenib formulations |
WO2009092070A1 (en) | 2008-01-17 | 2009-07-23 | Sicor Inc. | Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof |
WO2010079498A2 (en) * | 2009-01-12 | 2010-07-15 | Hetero Research Foundation | Novel polymorph of sorafenib tosylate |
EP2559431A1 (en) | 2011-08-17 | 2013-02-20 | Ratiopharm GmbH | Pharmaceutical composition comprising 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide |
-
2013
- 2013-01-23 ES ES13700919T patent/ES2949817T3/en active Active
- 2013-01-23 PL PL13700919.7T patent/PL2806860T3/en unknown
- 2013-01-23 IN IN1490KON2014 patent/IN2014KN01490A/en unknown
- 2013-01-23 WO PCT/EP2013/051219 patent/WO2013110644A1/en active Application Filing
- 2013-01-23 US US14/371,034 patent/US9227938B2/en active Active
- 2013-01-23 EP EP13700919.7A patent/EP2806860B1/en active Active
-
2023
- 2023-07-18 CY CY20231100340T patent/CY1126099T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1126099T1 (en) | 2023-11-15 |
US20150080435A1 (en) | 2015-03-19 |
US9227938B2 (en) | 2016-01-05 |
ES2949817T3 (en) | 2023-10-03 |
WO2013110644A1 (en) | 2013-08-01 |
EP2806860B1 (en) | 2023-04-19 |
PL2806860T3 (en) | 2023-09-11 |
EP2806860A1 (en) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245590A1 (en) | Oral product | |
HK1204232A1 (en) | Oral product | |
IL246377A0 (en) | Oral pharmaceutical composition | |
HK1209638A1 (en) | Pharmaceutical compositions | |
IL273076A (en) | Solid dosage form | |
EP2832730A4 (en) | Mirabegron-containing pharmaceutical composition | |
HK1199821A1 (en) | Oral pharmaceutical composition | |
PL3262951T3 (en) | Advanced gum forming | |
HK1199822A1 (en) | Oral pharmaceutical composition | |
IL266415A (en) | Novel pharmaceutical composition | |
CY1126099T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE SORAFENIB TOSYLATE | |
EP2844230A4 (en) | Pharmaceutical compositions for direct systemic introduction | |
EP2897590A4 (en) | Pharmaceutical composition | |
GB201211153D0 (en) | Pharmaceutical compositions | |
IL238075A0 (en) | Pharmaceutical compositions | |
GB201221130D0 (en) | New pharmaceutical composition | |
GB201219234D0 (en) | Pharmaceutical compositions | |
GB201213303D0 (en) | Pharmaceutical compositions | |
GB201207701D0 (en) | New pharmaceutical composition | |
GB201207628D0 (en) | New pharmaceutical composition | |
GB201204810D0 (en) | Pharmaceutical compositions |